Chemweb Events

New Approaches in Medicinal Chemistry Jan 27 2016
Conference: United Kingdom [in English]

Synopsis

This one day symposium is to be held at one of GSK’s major research and development centres in Stevenage. The event is aimed at introducing and reviewing a wide range of hot topics and approaches that may be used in discovering the drugs of tomorrow.

By bringing together speakers from the key global centres of excellence in drug discovery, the day has been designed to deliver what is current and of high interest to those pushing forward the frontiers of drug discovery. There will be discussion around the physicochemical property space that should guide successful drug design as well as when the traditional rules are not appropriate for meeting the requirements of a specific drug target or project.

Furthermore attention will be given to how a drug binds to its target and the importance of understanding the thermodynamic and kinetic profile of this binding event to guide further design iterations.

The day will also look to cover approaches and technologies such as DNA encoded libraries, chemoproteomics and novel ways of hit finding via activity directed synthesis.

Attendees

The meeting is aimed at scientists in the industrial and academic fields with a background in medicinal chemistry or drug discovery. It is ideally suited to those studying for a postgraduate degree or working in the pharmaceutical or biotechnology industry. This symposium will engage both those who are familiar with medicinal chemistry and drug discovery, and those who are new to the area but interested in learning more.

Event Location:
GlaxoSmithKline
Gunnels Wood Road
Stevenage
SG1 2NY
United Kingdom

Organizer:
Helen Gibb (send an email)
14-15 Belgrave Square
London
SW1X 8PS
United Kingdom
Deadlines
Early registration: Tuesday, January 26, 2016
Posters: Friday, December 4, 2015
Keynote speakers:

Dr Tim Ritchie, TJR-Chem, Italy

Dr Björn Over, AstraZeneca, Sweden

Dr Marcel Muelbaier, GSK, Germany

Dr Richard Ward, AstraZeneca, UK

Dr David Lawson, Takeda, USA

Dr Andrea Bortolato, Heptares, UK

Prof Adam Nelson, University of Leeds, UK

Dr Ghotas Evindar, GlaxoSmithKline, USA

Session titles:

Designing better molecules: using the past to predict the future

Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates

Thermal proteome profiling for unbiased identification of drug targets and detection of downstream effectors

The design and optimisation of covalent kinase inhibitors

Bigfoot, the Loch Ness Monster, and halogen bonds: separating rumors from reality in molecular design

High-end GPCR ligand design: from waters to kinetics

The realisation of activity-directed synthesis

DNA-encoded chemical libraries as a new paradigm in target chemical tractability assessment

Registration fees and grants:

Delegate Fees

Early bird fees before Friday 11 December 2015

GB£80 . . . . . . . . . . . . . . . . . SCI Member
GB£25 . . . . . . . . . . . . . . . . . SCI Student Member*
GB£55 . . . . . . .. . . . . . . . . . .SCI Subsidised Member
GB£110 . . . . . . . . . . . . . . . . Non-Member

Standard fees after Friday 11 December 2015

GB£100 . . . . . . . . . . . . . . . . SCI Member
GB£35 . . . . . . . . . . . . . . . . . SCI Student Member*
GB£65 . . . . . . . . . . . . . . . . . SCI Subsidised Member
GB£130 . . . . . . . . . . . . . . . . Non-Member

Academic Bursaries

Limited bursary places will be available to academic attendees with preference given to those presenting posters and SCI Student Members. This bursary will cover delegate registration fees not travel expenses. To register please email an application to conferences@soci.org by Friday 15 January 2016. You will be notified by Monday 18 January 2016 if your application has been successful.

Sponsors:

GlaxoSmithKline